KYMERA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
KYMERA THERAPEUTICS, INC. (KYMR) had Shares Outstanding (Cover Page) of 83.15 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 83.15M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 82.26M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 81.64M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 71.95M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 83.15M shares 10-Q · filed 2026-08-05 |
| 2026-04-24 | 82.26M shares 10-Q · filed 2026-04-30 |
| 2026-02-20 | 81.64M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 71.95M shares 10-Q · filed 2025-11-04 |
| 2025-08-08 | 71.50M shares 10-Q · filed 2025-08-11 |
| 2025-05-02 | 65.12M shares 10-Q · filed 2025-05-09 |
| 2025-02-21 | 64.94M shares 10-K · filed 2025-02-27 |
| 2024-10-25 | 64.77M shares 10-Q · filed 2024-10-31 |
| 2024-08-02 | 61.75M shares 10-Q · filed 2024-08-07 |
| 2024-04-26 | 61.36M shares 10-Q · filed 2024-05-02 |
| 2024-02-16 | 61.11M shares 10-K · filed 2024-02-22 |
| 2023-10-27 | 55.49M shares 10-Q · filed 2023-11-02 |
| 2023-07-28 | 55.41M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 55.31M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 55.18M shares 10-K · filed 2023-02-23 |
| 2022-10-28 | 54.86M shares 10-Q · filed 2022-11-03 |
| 2022-08-05 | 51.86M shares 10-Q · filed 2022-08-09 |
| 2022-04-29 | 51.72M shares 10-Q · filed 2022-05-03 |
| 2022-02-18 | 51.70M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 51.39M shares 10-Q · filed 2021-11-10 |
| 2021-07-30 | 51.04M shares 10-Q · filed 2021-08-06 |
| 2021-04-30 | 45.03M shares 10-Q · filed 2021-05-06 |
| 2021-02-26 | 44.81M shares 10-K · filed 2021-03-11 |
| 2020-10-30 | 44.46M shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |